Evidence map›Paper›PMID 42794894›Full record

ArticleCancers2026

Assessment of Clinical Time Intervals Along the Patient Journey with Overall Survival in Localized Osteosarcoma and Ewing Sarcoma: A 20-Year Tertiary Sarcoma Centre Experience.

Roberta Laranga, Cristina Ferrari, Federica Zuccheri, Valentina Clementi, Giuseppe Bianchi

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roberta LarangaDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0002-4021-9694
Cristina FerrariLaboratory of Oncology Research and Functional Genomics, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0002-7755-5085
Federica ZuccheriDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Valentina ClementiDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Giuseppe BianchiDepartment of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0001-6390-9762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe impact of healthcare-related time intervals on outcomes in bone sarcomas remains controversial. We evaluated the impact of clinically defined post-referral, in-hospital care intervals on overall survival (OS) and their variation over two decades, in patients treated at a tertiary sarcoma centre.

methodsWe retrospectively analysed 506 patients with localized osteosarcoma (

resultsMedian PJT was longer in Ewing's sarcoma than in osteosarcoma (17 vs. 14 days;

conclusionsWithin the specialized tertiary centre setting, longer in-hospital care timelines were not associated with poorer overall survival despite increasing over time, a finding that may reflect the growing complexity of multidisciplinary management exclusively during the post-referral phase.

Indexed as

bone sarcomaclinical time intervalsEwing’s sarcomaosteosarcomaoverall survivaltertiary referral centretime to treatment initiation

Identifiers

PMID42794894
PMCPMC13604304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.